(H4Z3) HSBC MSCI Emerging Markets - Ratings and Ratios
Equity, Shares, Emerging, Markets, ETF
Description: H4Z3 HSBC MSCI Emerging Markets
The HSBC MSCI Emerging Markets UCITS ETF USD Acc EUR is an exchange-traded fund listed on the XETRA exchange with the ticker symbol H4Z3. It is designed to track the Morningstar Emerging Markets TME NR USD Index, providing investors with exposure to a broad range of emerging markets equities.
As a Global Emerging Markets Equity ETF, it offers a diversified portfolio that captures the growth potential of emerging economies. The fund is domiciled in Germany and is structured as a UCITS-compliant ETF, making it accessible to a wide range of investors across Europe.
From a technical analysis perspective, the ETFs price action indicates a bullish trend, with the short-term Simple Moving Average (SMA20) at 11.04 EUR and the long-term SMA200 at 10.91 EUR. The current price of 11.15 EUR is above both SMAs, suggesting an upward momentum. The Average True Range (ATR) of 0.12 EUR or 1.06% indicates moderate volatility, and the 52-week high and low of 11.65 EUR and 9.45 EUR, respectively, suggest a relatively stable price range.
With Assets Under Management (AUM) of 2637.67M EUR, the fund has a significant presence in the market, indicating strong investor interest. The size of the fund also suggests that it has sufficient liquidity, making it easier for investors to enter or exit positions.
Based on the technical and fundamental data, a forecast for the HSBC MSCI Emerging Markets UCITS ETF USD Acc EUR could be as follows: Given the bullish trend indicated by the SMAs and the current price, we can expect the ETF to continue its upward trajectory. However, the moderate volatility indicated by the ATR suggests that there may be some fluctuations along the way. With a strong AUM and a diversified portfolio, the fund is well-positioned to capitalize on the growth potential of emerging markets. Therefore, a potential price target for the ETF could be in the range of 11.50-12.00 EUR in the short to medium term, contingent on the continued growth of the underlying index.
Additional Sources for H4Z3 ETF
H4Z3 ETF Overview
Market Cap in USD | 3,082m |
Category | Global Emerging Markets Equity |
IPO / Inception | 2022-06-28 |
H4Z3 ETF Ratings
Growth Rating | 34.1 |
Fundamental | - |
Dividend Rating | 0.0 |
Rel. Strength | -17.9 |
Analysts | - |
Fair Price Momentum | 10.25 EUR |
Fair Price DCF | - |
H4Z3 Dividends
Currently no dividends paidH4Z3 Growth Ratios
Growth Correlation 3m | 80.2% |
Growth Correlation 12m | 38% |
Growth Correlation 5y | 77.7% |
CAGR 5y | 5.27% |
CAGR/Max DD 5y | 0.28 |
Sharpe Ratio 12m | 0.34 |
Alpha | -1.17 |
Beta | 0.618 |
Volatility | 13.18% |
Current Volume | 46.3k |
Average Volume 20d | 32k |
Stop Loss | 11.1 (-2.9%) |
As of July 16, 2025, the stock is trading at EUR 11.43 with a total of 46,251 shares traded.
Over the past week, the price has changed by +1.52%, over one month by +2.48%, over three months by +12.77% and over the past year by +5.71%.
Neither. Based on ValueRay´s Analyses, HSBC MSCI Emerging Markets is currently (July 2025) neither a good nor a bad stock to buy. It has a ValueRay Growth Rating of 34.08 and therefor a technical neutral rating according to historical growth.
Based on momentum, paid dividends and discounted-cash-flow analyses, the fair value of H4Z3 is around 10.25 EUR . This means that H4Z3 is currently overvalued and has a potential downside of -10.32%.
HSBC MSCI Emerging Markets has no consensus analysts rating.
According to our own proprietary Forecast Model, H4Z3 HSBC MSCI Emerging Markets will be worth about 11.5 in July 2026. The stock is currently trading at 11.43. This means that the stock has a potential upside of +0.79%.
Issuer | Target | Up/Down from current |
---|---|---|
Wallstreet Target Price | - | - |
Analysts Target Price | - | - |
ValueRay Target Price | 11.5 | 0.8% |